April 14, 2006
Merck and Fosamax
Posted at April 14, 2006 12:49 PM in Drug Products
.
It appears the manufacturer of Fosamax, the osteoporosis drug, knew about potential serious problems with the drug back in 2004. Fosamax belongs to a family of drugs called bisphosphonates which are believed to cause a severe osteonecrosis. Merck has made $3million from Fosamax and didn't want to change its labeling for fear of declining sales. Sound familiar?
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/261 .